Bio-Works Technologies AB Capital Reinvestment Ratio

Latest as of June 2021: 0.10x

Bio-Works Technologies AB capital reinvestment ratio. Bio-Works Technologies AB (BIOWKS) has a Capital Reinvestment Ratio of 0.10x as of June 2021, meaning it reinvests 0% of its operating cash flow (Skr9.35 Million) in capital expenditures (Skr891.00K). Check Bio-Works Technologies AB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.10x

Capex / Operating Cash Flow

Operating Cash Flow

Skr9.35 Million

SEK

Capital Expenditures

Skr891.00K

SEK

Data as of

Jun 2021

Most recent filing

Bio-Works Technologies AB Capital Reinvestment Ratio by Year (None–None)

Bio-Works Technologies AB capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Bio-Works Technologies AB (BIOWKS) cash conversion ratio.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow